Human Genome Sciences Inc (NASDAQ: HGSI) Continues Advance Says Market Timer Frank Kollar
September 13, 2007 (FinancialWire) (By Frank Kollar)
Shares of Human Genome Sciences Inc (NASDAQ: HGSI) continued to move higher along with the entire biotechnology sector. How high can they go?
Human Genome Sciences closed above the 50% retracement of the steep April to August decline. The odds favor a run to at least $9.85 in coming days, and more likely $10.61 in the coming weeks. A close above $10.61 would open up the potential for a recovery of most, if not all, of the November 2006 through August 2007 sell off.
The Fibtimer.com (http://www.fibtimer.com) Stock Timing Strategy currently has a position in Human Genome Sciences.
Follow your strategy and adhere to money management rules to protect capital. If you do not have money management rules, give FibTimer.com (http://www.fibtimer.com) a call. The surest way to lose money in the stock market is to trade without a plan.
Kollar’s research has shown that the financial markets are in tradable trends approximately 80 percent of the time. FibTimer strategies define trends and trade them in both advancing and declining markets. Caring nothing about what newscasters say or what the latest economic indicator predicts, trends are where the profits are, and that is where FibTimer is.
Kollar is editor and chief analyst at FibTimer.com (http://www.fibtimer.com) which offers market timing strategies for S&P and Nasdaq index fund traders, as well as bond, gold, small cap, sector, ETF and stock trading strategies.
Go to previous Press Releases & Trading Notes.
Note: These "Trading Notes" are short term in nature. They may or may not reflect the same position as current subscriber reports which typically have longer time frames.
© Copyright 1996-2007, Kollar Market Analytics, Inc., All Rights Reserved.
FibTimer reports may not be redistributed without permission. These Trading Notes however may be distributed without permission.
Disclaimer: The financial markets are risky. Investing is risky. Past performance
does not guarantee future performance. The foregoing has been prepared solely
for informational purposes and is not a solicitation, or an offer to buy or sell
any security. Opinions are based on historical research and data believed reliable,
but there is no guarantee that future results will be profitable. |
